CJC-1295

A long-acting growth hormone-releasing peptide for extended research applications

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH), engineered with a Drug Affinity Complex (DAC) modification for extended stability and a prolonged half-life. Unlike native GHRH, CJC-1295 supports sustained elevation of endogenous growth hormone and IGF-1 levels, making it a widely referenced compound in growth hormone research protocols.